Fundraising Fox
Halomine
Founded 2018 · 18 employees on LinkedIn · 4 known investors
Find your way into Halomine
Sign up to see every warm intro you have to Halomine
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Halomine team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AvantGuard develops Avantamine, an antimicrobial molecule that eliminates bacteria, viruses, and fungi on surfaces and skin without generating resistance, with an initial focus on topical treatment of the drug-resistant fungal pathogen Candida auris. The technology can be formulated as an antiseptic, disinfectant, surface coating, or plastics additive for use in healthcare settings.
Investors · 4
How we know: Red Bear Angels's portfolio page · funding news · avantguardinc.com · Not right? Tell us
How we know: in-icorps.org · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountseed funding roundJun 2023
Blue Ledge Capital, LaunchNY, Red Bear Angels, SOSV
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Non-dilutive funding · 9 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $325K |
| Department of Agriculture (USDA) | Phase I | 2022 | $175K |
| National Science Foundation | Phase II | 2021 | $1M |
| Department of Agriculture (USDA) | Phase II | 2020 | $600K |
| National Science Foundation | Phase I | 2020 | $256K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $250.3K |
| National Science Foundation | Phase I | 2020 | $225K |
| U.S. ArmyArmy | Phase I | 2020 | $99.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Halomine do?
- AvantGuard develops Avantamine, an antimicrobial molecule that eliminates bacteria, viruses, and fungi on surfaces and skin without generating resistance, with an initial focus on topical treatment of the drug-resistant fungal pathogen Candida auris. The technology can be formulated as an antiseptic, disinfectant, surface coating, or plastics additive for use in healthcare settings.
- Who are Halomine's investors?
- Halomine's investors include Red Bear Angels, Blue Ledge Capital, SOSV.